logo

Before The Bell

Share

Goldman Sachs upgraded its rating on shares of Wal-Mart Stores Inc. (WMT) Thursday morning to "Buy" from "Neutral." Wal-Mart Stores gapped up sharply Thursday, but traded in a range for the majority of the session. Shares finished with a gain of 1.60 at $104.30. The stock climbed to its second consecutive...

Alcoa Inc. (AA) reported fourth quarter adjusted EPS of $1.04 after the bell Wednesday, which fell short of the consensus estimate of $1.22. Sales for the quarter rose to $3.17 billion from $2.54 billion last year. Analysts expected revenues of $3.29 billion. Alcoa gapped open sharply lower Thursday...

Electro Scientific Industries (ESIO) announced after the bell Wednesday that it expects to report third quarter revenue of $106 million to $111 million. The consensus estimate is for revenues of $85 million. Adjusted EPS is expected to exceed the guidance range the company had previously provided...

Papa John's International (PZZA) rose steadily during the first 2 hours of trade Thursday, but settled into a range for the rest of the session. Shares finished with a gain of 4.69 at $63.78 on above average volume. Papa John's broke out of a trading range at the lows of the year and set a 2 1/2 month high.

Wyndham Worldwide (WYN) announced Thursday morning that it has agreed to acquire La Quinta's hotel franchise and hotel management businesses for $1.95 billion in cash. Wyndham gapped up and rose sharply in early trade Thursday, but settled into a range for the majority of the day. The stock closed...

M&T Bank Corp. (MTB) reported fourth quarter EPS of $2.01 Thursday morning, up from $1.98 in the prior year period. Street expectations were for EPS of $2.40. M&T Bank spiked to the upside in early trade Thursday, but settled into a range for the majority of the session. The stock closed up by 6.94...

Goldman Sachs Group (GS) reported fourth quarter adjusted EPS of $5.68 Wednesday morning, which topped the consensus estimate of $4.92. Net revenues decreased 4 percent to $7.83 billion from $8.17 billion in the prior year. Analysts expected revenues of $7.61 billion. Goldman Sachs declined during...

Barclays upgraded its rating on shares of IBM Corp. (IBM) Wednesday morning to "Overweight" from "Underweight." IBM gapped open higher Wednesday and advanced further in the early afternoon. The stock finished with a gain of 4.80 at $168.65 on above average volume. IBM has been climbing for the past...

Morgan Stanley downgraded its rating on shares of Dish Network Corp. (DISH) Wednesday morning to "Equal-weight" from "Overweight." Dish Network gapped open lower Wednesday and fell during the first half hour of trade, before settling into a range. The stock closed down by 2.54 at $45.45 with volume...

Fastenal Co. (FAST) reported fourth quarter adjusted EPS of $0.45 Wednesday morning, which was in line with analysts' expectations. Fastenal gapped open lower Wednesday and slid further around mid-morning. The stock ended the day with a loss of 3.24 at $52.20 with volume at a 3-month high. Fastenal...

EXACT Sciences Corp. (EXAS) declined during the first half of the morning Wednesday, but settled into a range for the rest of the session. Shares finished with a loss of 5.27 at $47.68 with volume at an 8-month high. EXACT Sciences dropped below over a 1-month trading range and set a 3-month low....

The Wall Street Journal reported Tuesday that Celgene (CELG) is in talks to acquire Juno Therapeutics Inc. (JUNO). Juno Therapeutics gapped open dramatically higher Wednesday morning, but was range-bound throughout the session. The stock closed up by 23.65 at $69.25 on the highest volume of the year....

Avis Budget Group (CAR) announced Monday that its Board has approved the adoption of a one-year Stockholder Rights Plan. Avis Budget Group declined for the majority of the morning Monday and slipped further around mid-afternoon. Shares finished with a loss of 6.64 at $42.51 on the highest volume...

Eiger BioPharmaceuticals Inc. (EIGR) announced Tuesday morning that its Phase 2 study of ubenimex in pulmonary arterial hypertension demonstrated no improvement for both the primary endpoint of pulmonary vascular resistance and the secondary endpoint of 6-minute walk distance. Eiger BioPharmaceuticals...

Merck & Co. Inc. (MRK) announced Tuesday morning that its Phase 3 trial of KEYTRUDA in combination with pemetrexed and cisplatin or carboplatin, for the first-line treatment of patients with metastatic non-squamous non-small cell lung cancer, met its dual primary endpoints of overall survival and progression-free...

Follow RTT